A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants

Zhu, Q; McLellan, JS; Kallewaard, NL; Ulbrandt, ND; Palaszynski, S; Zhang, J; Moldt, B; Khan, A; Svabek, C; McAuliffe, JM; Wrapp, D; Patel, NK; Cook, KE; Richter, BWM; Ryan, PC; Yuan, AQ; Suzich, JA

Zhu, Q; Suzich, JA (reprint author), MedImmune LLC, Dept Infect Dis, One MedImmuneWay, Gaithersburg, MD 20878 USA.

SCIENCE TRANSLATIONAL MEDICINE, 2017; 9 (388):

Abstract

Prevention of respiratory syncytial virus (RSV) illness in all infants is a major public health priority. However, no vaccine is currently available t......

Full Text Link